resistant to doxorubicin i.e. adriamycin
| Inventor | Institute |
|---|---|
| Martin Clynes | Dublin City University |
| SKU: | 157984 |
|---|---|
| Product description: | resistant to doxorubicin i.e. adriamycin. Epithelial model |
| Production details: | Developed from an OAW42 population with spontaneous resistance to doxorubicin – then made more resistant by prolonged exposure with 0.85 ug/ml doxorubicin |
| Parental cell line: | OAW42 (ECACC #85073102) |
| Disease: | Cancer |
| Cat. #: | 157984 |
|---|---|
| Tool sub type: | Continuous |
| Unit size: | 1×10^6 cells / vial |
| Cancer types: | Ovarian cancer |
| Research Fields: | Cancer; Drug development |
| Organism: | Human |
| Growth properties: | monolayer |
| Cancer Types In Detail: | Ovarian cystadenocarcinoma |
| Format: | Frozen |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry ice |
| Growth medium: | DMEM/Ham’s F12, 10% FCS. Split 1:3 to 1:6, medium change 2-3 times weekly. Freezing method: 5% DMSO in FBS |
| Recommended controls: | OAW42 parental line |
| Mycoplasma free: | Yes |
| Biosafety level: | 1 |
| References: |
NicAmhlaoibh et al. 1999. Int J Cancer. 82(3):368-76. PMID: 10399954. Moran et al. 1997. Eur J Cancer. 33(4):652-60. PMID: 9274450. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.